AvaSure, a market leader in acute virtual care, and CLEW Medical, an AI-enabled clinical surveillance and predictive analytics company, announced their partnership to drive early detection of critical care patient deterioration. from AvaSure Teams Up with CLEW Medical to Boost High-Acuity Care with AI-Driven Virtual Surveillance
CLEW Medical is unveiling new FDA-cleared machine learning algorithms that not only reduce patient condition alerts, but have also been shown to increase accuracy in detecting clinical deterioration. from Healthcare IT News: AI tackles patient deterioration, obesity and stroke
CLEW announced that its second-generation, AI/machine-learning models for predicting patient deterioration have received 510(k) clearance from the Food & Drug Administration (FDA). from CLEW MEDICAL SECURES FDA CLEARANCE FOR SECOND-GENERATION AI MODELS
The FDA-cleared system is proven to accurately predict patient deterioration, reduce caregiver burden and create opportunities for early intervention. from CLEW EXPANDS ITS INTELLIGENT CLINICAL SURVEILLANCE PLATFORM TO ALL INPATIENT SETTINGS
A study shared by CHEST Journal finds that CLEW’s FDA-cleared AI-driven models for predicting patient deterioration were five times more accurate than alerts from a leading telemedicine system. from STUDY FINDS AI-DRIVEN PREDICTION MODELS ACCURATELY PREDICT CRITICAL CARE PATIENT DETERIORATION AND SIGNIFICANTLY REDUCE FALSE ALARMS FOR CLINICIANS
"*" indicates required fields